Loading…
← CockpitCompetitor Analysis › 603360.SS Dalian Bio-Chem Co., Ltd. Class AOpen in the cockpit ↗

Dalian Bio-Chem Co., Ltd. Class A603360.SSCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Major Diversified

Dalian-based biochemical company; specific product line not established from available knowledge.

Momentum laggard 8
Mkt cap
$971M
US dollars, full cap
Free float
41%
of shares outstanding
$/day
$16.5M
20-day average traded
Fwd P/E
21.7×
forward earnings
ROIC−WACC
+2.4 pp
WACC 5.7%
Hurdle
-10 pp
Req g minus delivered
Next earnings
156 days
23 Apr 2027
Close · CNYCN¥9.50
1D+0.8%
1W-9.4%
1M-15.6%
3M-30.1%
6M-53.7%
YTD-70.5%
1Y-69.8%
ATR %5.8%
52w lowhigh75.6% off high

What Dalian Bio-Chem does

Dalian-based biochemical company; specific product line not established from available knowledge.

Where it sits in the supply chain

  • Materials

Moat: none

Headquarters: Dalian, China · Employees: 1,053

Dalian Bio-Chem at a glance

Size Dalian Bio-Chem (603360.SS) is a China Materials company (Chemicals: Major Diversified) with a market value of $971M, the 2207th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥9.50 on 18 Nov 2026.

Performance Over six months the shares fell 53.7%, against -26.9% for the median peer and -20.0% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue grew 0.4% over the last twelve months (peer median +5.9%); the operating margin is 16.2% (peer median 11.1%).

Valuation It trades at 21.7× forward earnings against a peer median of 21.6× (7th most expensive of 14).

Price implies For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -10 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.4 points above its cost of capital (5.7% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

507510021 May 202621 Aug 202618 Nov 2026Peer median 74603360.SS 42
Six months, rebased to 100: Dalian Bio-Chem against the median of its 20 peers (local-currency closes).

Dalian Bio-Chem financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.48BCN¥1.72BCN¥1.26BCN¥1.05BCN¥1.24B
Revenue growth—+36%+20%-15%—
Gross profitCN¥611MCN¥598MCN¥542MCN¥529MCN¥638M
EBITDAn/aCN¥473MCN¥429MCN¥427MCN¥517M
Net incomeCN¥146MCN¥210MCN¥392MCN¥328MCN¥403M
Free cash flowCN¥167MCN¥510MCN¥89.0MCN¥323MCN¥347M
Capital expenditureCN¥118MCN¥36.7MCN¥74.9MCN¥67.4MCN¥134M
Total debtCN¥1.33BCN¥1.38BCN¥608MCN¥180MCN¥129M

Quarterly statements and history in the cockpit →

Dalian Bio-Chem competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%214370JUBLINGREARPEL3006417666VCT60318130077960320060032868835947636032816031554471LXS301393000420002585603360.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Dalian Bio-Chem is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×50×100×214370JUBLINGREAVCT60318130077947636032816031554471301393000420002585603360.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Dalian Bio-Chem is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%214370JUBLINGREA300641VCT47636032816031554471LXS4975603360.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Dalian Bio-Chem is the large dot.

Dalian Bio-Chem competitors and peer comparison

How Dalian Bio-Chem compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Dalian Bio-Chem against its 20 peers (data as of 18 Nov 2026)
Measure603360.SSPeer medianRank in peer set
1-month return-15.6%-13.5%10th lowest of 21
6-month return-53.7%-26.9%4th lowest of 21
Distance from 52-week high-75.6%-46.0%4th lowest of 21
Revenue growth (TTM)+0.4%+5.9%9th lowest of 21
Operating margin16.2%11.1%9th highest of 21
Forward P/E21.7×21.6×7th most expensive of 14
Growth the price implies (Req g, 7 yrs)8.5%7.1%6th most demanding of 12
Growth delivered (Del g)+18.4%+3.9%3rd highest of 12
Hurdle (Req g minus delivered)-9.8 pp-1.5 pp3rd least demanding of 12
ROIC minus cost of capital+2.4 pp-2.1 pp6th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Dalian Bio-Chem 603360.SSChina$971M-54%0%16%21.7×8.5%+18.4%
Caregen 214370.KSSouth Korea$982M-74%-2%20%21.5×36.8%+3.8%
Jubilant Ingrevia JUBLINGREA.NSIndia$1.00B-19%+15%10%21.6×28.0%+44.9%
Raghav Productivity Enhancers RPEL.NSIndia$942M+109%+38%28%n/an/an/a
Jiangsu Zhengdan Chemical Industry 300641.SZChina$914M-29%-30%17%n/a7.1%+11.6%
Metis TechBio 7666.HKHong Kong$1.05B-64%+6,987%-367%n/an/an/a
Victrex VCT.LUnited Kingdom$1.06B+46%-1%14%22.5×16.7%+1.9%
Zhejiang Huangma Technology 603181.SSChina$891M-33%+7%17%13.8×n/an/a
Qingdao Huicheng Environmental Technology 300779.SZChina$1.08B-48%-13%5%69.5×n/an/a
Shanghai Emperor of Cleaning Hi-Tech 603200.SSChina$1.12B-24%+4%-8%n/an/an/a
CNSIG Inner Mongolia Chemical Industry 600328.SSChina$1.12B-36%-20%-7%n/an/an/a
Guangzhou Sanfu Newmaterials Technology 688359.SSChina$832M-54%+8%-7%n/an/an/a
Jinan Acetate Chemical 4763.TWTaiwan$1.14B-5%-24%43%6.6×-20.2%+41.2%
Hubei Jianghan New Materials 603281.SSChina$1.15B-38%+8%17%21.1×3.9%+6.3%
Xinyaqiang Silicon Chemistry 603155.SSChina$798M-15%+25%12%37.4×22.5%+3.9%
Sanyo Chemical Industries 4471.TJapan$794M+8%+8%11%9.6×-7.2%-2.5%
Lanxess LXS.DEGermany$1.19B-24%-4%0%n/a5.3%-1.5%
Suzhou Highfine Biotech 301393.SZChina$786M-15%+36%17%29.4×n/an/a
Jilin Chemical Fibre Stock 000420.SZChina$1.20B-34%+11%5%130.4×n/an/a
JCU 4975.TJapan$744M-34%+5%39%13.4×5.5%+7.0%
Jiangsu Shuangxing Color Plastic New Materials 002585.SZChina$1.27B-10%-4%-4%57.9×21.0%+0.2%

Questions

Which companies are Dalian Bio-Chem's closest peers?
The cockpit's peer set: Caregen (214370.KS), Jubilant Ingrevia (JUBLINGREA.NS), Raghav Productivity Enhancers (RPEL.NS), Jiangsu Zhengdan Chemical Industry (300641.SZ), Metis TechBio (7666.HK), Victrex (VCT.L), Zhejiang Huangma Technology (603181.SS), Qingdao Huicheng Environmental Technology (300779.SZ).
Is Dalian Bio-Chem expensive compared with its peers?
On forward p/e it trades at 21.7× against a peer median of 21.6×, 7th most expensive of 14 in its peer set. For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -10 pp: the price already allows for a slowdown.
How has Dalian Bio-Chem stock performed?
Over six months to 18 Nov 2026 the shares returned -53.7% against -26.9% for the median peer; over one year -69.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.